XIAP and breast carcinoma: Nestal de Moraes et al. [43] have shown that FOXM1 upregulates antiapoptotic genes XIAP and survivin by interacting with their promoters, contributing to chemoresistance of breast cancer cells to docetaxel, paclitaxel, and epirubicin.